Picture of Item 9 Labs logo

INLB Item 9 Labs Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Item 9 Labs, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2018
September 30th
2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.689-9.95-12.3-10.9-31.2
Depreciation
Amortisation
Non-Cash Items0.077.147.156.5719.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.403-0.2613.1-2.887.86
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-0.972-2.39-1.14-5.99-2.25
Capital Expenditures-0.34-7.51-0.723-2.24-5.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.023-0.336-0.164-1.680.442
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-0.363-7.84-0.887-3.92-5.16
Financing Cash Flow Items-0.05-0.071
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities39.141.5411.36.05
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.66-1.1-0.491.37-1.37